Source - SMW
Concepta, the UK healthcare company targeting the personalised mobile health market with a primary focus on women's fertility, has signed a manufacturing agreement with Shijiazhuang Huanzhong Biotech Limited, a leading Chinese manufacturer with operations in Shijiazhuang, to assemble and package Concepta's 'My Lotus' fertility product. 

The company says this  agreement is in line with its strategy as it builds towards the launch of its My Lotus product for unexplained infertility into China in H2 2016.

Under the terms of the agreement, HZ Biotech will exclusively assemble and package Concepta produced components (including bulk tests and electronic meters), to produce Concepta's My Lotus product to specification for the Chinese market.  HZ will utilise its manufacturing site and processes, adhering to locally applicable laws and Chinese regulatory requirements. 

 In addition to assembling the final My Lotus product, HZ Biotech will be the sole purchaser of Concepta's My Lotus product and help facilitate its launch to the Chinese market and include post-market surveillance. Concepta will also look to work with a network of distributors in China to help achieve maximum market penetration in China and will update the market on these developments in due course.




Related Charts

Concepta Ord 2.5p (CPT)

+0.25p (+1.45%)
delayed 18:15PM